A detailed history of Abound Wealth Management transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Abound Wealth Management holds 111 shares of DGX stock, worth $15,216. This represents 0.01% of its overall portfolio holdings.

Number of Shares
111
Previous 111 -0.0%
Holding current value
$15,216
Previous $14.8 Million 2.83%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 08, 2024

BUY
$123.78 - $142.11 $123 - $142
1 Added 0.91%
111 $14.8 Million
Q4 2023

Aug 08, 2024

BUY
$120.62 - $141.12 $1,447 - $1,693
12 Added 12.24%
110 $15.2 Million
Q3 2023

Aug 08, 2024

SELL
$121.86 - $144.92 $243 - $289
-2 Reduced 2.0%
98 $12 Million
Q2 2023

Aug 08, 2024

BUY
$130.56 - $146.84 $10,053 - $11,306
77 Added 334.78%
100 $14.1 Million
Q1 2023

Aug 07, 2024

BUY
$131.53 - $155.76 $3,025 - $3,582
23 New
23 $3.26 Million
Q3 2022

Aug 07, 2024

SELL
$121.77 - $141.1 $1,095 - $1,269
-9 Reduced 39.13%
14 $1.72 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.